News

Shortage of Infectious Disease Doctors and Why This Matters

Shortage of Infectious Disease Doctors and Why This Matters

Dr. Danielle Zerr, MD, MPH, Medical Director of Infection Prevention at Seattle Children’s discusses the expected severe shortage of infectious disease specialists over the next decade, according to projections by the federal Health Resources and Services Administration. She talks about why this shortage matters, some of the challenges in the profession, why she has devoted herself to the infectious disease prevention profession, and the benefits of choosing this specialty.

Frequently Asked Questions

What is the main topic discussed in this episode of Health Professional Radio?

This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.

How can healthcare professionals benefit from this information?

Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.

Where can I find more information about Cancer?

For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.

Dr. Zerr’s research has focused on two main areas:(1) defining the epidemiology of viral pathogens in healthy children and immunocompromised hosts and (2) describing the epidemiology and defining prevention strategies for healthcare-associated infections. Recent work includes studies aimed at defining the epidemiology of human herpesvirus 6 (HHV-6) in hematopoietic stem cell transplant recipients. In addition, Dr. Zerr collaborates with Dr. Weissman and Dr. Qin in investigating the molecular epidemiology of broad-spectrum beta-lactam resistance in pediatric Enterobacteriaceae infections. Dr. Zerr also leads a multicenter trial aimed at reducing healthcare-associated infections in children with cancer.

Last updated: March 29, 2023

Medical Disclaimer

The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.